Genetic variants in antioxidant pathway: Risk factors for hepatotoxicity in tuberculosis patients

World Health Organization: global tuberculosis control 2009-epidemiology, strategy, financing: WHO report 2009, WHO/HTM/TB/2009.411. World Health Organization, Geneva, Switzerland. Dye, 2002, Worldwide incidence of multidrug-resistant tuberculosis, J Infect Dis, 185, 1197, 10.1086/339818 Corbett, 2003, The growing burden of tuberculosis: global trends and interactions with the HIV epidemic, Arch Intern Med, 163, 1009, 10.1001/archinte.163.9.1009 Pande, 1996, Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study, Thorax, 51, 132, 10.1136/thx.51.2.132 Dossing, 1996, Liver injury during antituberculosis treatment: an 11-year study, Tuber Lung Dis, 77, 335, 10.1016/S0962-8479(96)90098-2 Devoto, 1997, Risk factors for hepatotoxicity induced by antituberculosis drugs, Acta Physiol Pharmacol Ther Latinoam, 47, 197 Wong, 2000, Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection, Hematology, 31, 201 Shakya, 2004, Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors, Ann Pharmacophore, 38, 1074, 10.1345/aph.1D525 Ungo, 1998, Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus, Am J Respir Crit Care Med, 157, 1871, 10.1164/ajrccm.157.6.9711039 Ohno, 2000, Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity, Int J Tuberc Lung Dis, 4, 256 Huang, 2002, Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis, Hepatology, 35, 883, 10.1053/jhep.2002.32102 Hussain, 2003, Antituberculosis drug-induced hepatitis: risk factors, prevention and management, Indian J Exp Biol, 41, 1226 Shimizu, 2006, DNA microarray genotyping of N-acetyltransferase 2 polymorphism using carbodiimide as the linker for assessment of isoniazid hepatotoxicity, Tuberculosis, 86, 374, 10.1016/j.tube.2005.09.002 Higuchi, 2007, NAT2∗6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis, World J Gastroenterol, 13, 6003, 10.3748/wjg.v13.45.6003 Huang, 2003, Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis, Hepatology, 37, 924, 10.1053/jhep.2003.50144 Roy, 2001, Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 ’null’ mutation, J Gastroenterol Hepatol, 16, 1033, 10.1046/j.1440-1746.2001.02585.x Sharma, 2002, Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment, Am J Respir Crit Care Med, 166, 916, 10.1164/rccm.2108091 Timbrell, 1979, Studies on the role of acetylhydrazine in isoniazid hepatotoxicity, Arch Toxicol Suppl, 2, 1, 10.1007/978-3-642-67265-1_1 Noda, 1983, Is isoniazid-hepatotoxicity induced by the metabolite, hydrazine?, J UOEH, 5, 183 Lauterburg, 1985, Oxidation of hydrazine metabolites formed from isoniazid, Clin Pharmacol Ther, 38, 566, 10.1038/clpt.1985.225 Sodhi, 1996, Study of oxidative stress in isoniazid-induced hepatic injury in young rats with and without protein-energy malnutrition, J Biochem Toxicol, 11, 139, 10.1002/(SICI)1522-7146(1996)11:3<139::AID-JBT6>3.0.CO;2-L Zhen, 2008, Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species, Am J Hypertens, 21, 28, 10.1038/ajh.2007.14 Jaeschke, 2003, The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity, Toxicol Lett, 144, 279, 10.1016/S0378-4274(03)00239-X Talalay, 2003, Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis, Adv Enzym Regul, 43, 121, 10.1016/S0065-2571(02)00038-9 Primiano, 1997, Antioxidant-inducible genes, Adv Pharmacol, 38, 293, 10.1016/S1054-3589(08)60989-8 Itoh, 1997, An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements, Biochem Biophys Res Commun, 236, 313, 10.1006/bbrc.1997.6943 Oyake, 2006, Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site, Mol Cell Biol, 16, 6083, 10.1128/MCB.16.11.6083 Igarashi, 1998, Multivalent DNA binding complex generated by small Maf and Bach1 as a possible biochemical basis for γ-globin locus control region complex, J Biol Chem, 273, 11783, 10.1074/jbc.273.19.11783 Itoh, 1999, Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, Genes Dev, 13, 76, 10.1101/gad.13.1.76 Suzuki, 2004, Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1, EMBO J, 23, 2544, 10.1038/sj.emboj.7600248 2000, American Thoracic Society: diagnostic standards and classification of tuberculosis in adults and children, Am J Respir Crit Care Med, 161, 1376 Benichou, 1990, Criteria of drug-induced liver disorders. Report of an international consensus meeting, J Hepatol, 11, 272, 10.1016/0168-8278(90)90124-A 2007, The International HapMap Consortium: a second generation human haplotype map of over 3.1 million SNPs, Nature, 449, 851, 10.1038/nature06258 Barrett, 2005, Haploview: analysis and visualization of LD and haplotype maps, Bioinformatics, 21, 263, 10.1093/bioinformatics/bth457 Ogawa, 2001, Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1, EMBO J, 20, 2835, 10.1093/emboj/20.11.2835 MacLeod, 2009, Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds, Carcinogenesis, 30, 1571, 10.1093/carcin/bgp176 Knight, 2001, Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress, Toxicol Sci, 62, 212, 10.1093/toxsci/62.2.212 Kon, 2004, Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes, Hepatology, 40, 1170, 10.1002/hep.20437 Cover, 2005, Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity, J Pharmacol Exp Ther, 315, 879, 10.1124/jpet.105.088898 Yoh, 2001, Transgenic over-expression of MafK suppresses T cell proliferation and function in vivo, Genes Cells, 6, 1055, 10.1046/j.1365-2443.2001.00489.x Gardner, 1998, Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat, Hepatology, 27, 748, 10.1002/hep.510270316 Gardner, 2002, Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-alpha and interleukin-10, Toxicol Appl Pharmacol, 184, 27, 10.1006/taap.2002.9474 Pryor, 1995, The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide, Am J Physiol, 268, L699 Moreno, 1992, Inactivation of α1-proteinase inhibitor by peroxynitrite, Chem Res Toxicol, 5, 425, 10.1021/tx00027a017